Speak directly to the analyst to clarify any post sales queries you may have.
The global mesalamine API market is rapidly evolving as manufacturers and pharmaceutical developers respond to shifting regulatory landscapes, emerging technologies, and growing demand for advanced gastrointestinal treatments. Decision-makers must stay ahead of complex supply chain, cost, and compliance challenges to seize new opportunities and sustain competitive positioning.
Market Snapshot: Mesalamine API Market Dynamics
The mesalamine API market is projected to grow at a CAGR of [data unavailable] and is valued at [data unavailable]. Increasing prevalence of chronic gastrointestinal disorders, innovative drug delivery formulations, and rising global healthcare expenditures are key factors fueling this expansion. Market growth is further supported by regulatory approvals for novel release profiles, advancements in real-time process analytics, and ongoing interest from both established manufacturers and emerging players looking to differentiate their offerings.
Scope & Segmentation Overview
- Formulation Types: Capsule (enteric coated, nonenteric), Granules, Suspension, Tablet (extended release, immediate release).
- Therapeutic Areas: Crohn’s Disease (colonic, ileal, ileocolonic), Ulcerative Colitis (mild, moderate, severe).
- Delivery Routes: Oral ingestion, rectal administration (enema, suppository).
- End User Segments: Contract manufacturing organizations (domestic, international), generic manufacturers (mid size, small scale), pharma companies (generic, innovator).
- Sales Channels: Direct tender (government, hospital), distributors (national, regional), online platforms (B2B portals).
- Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
- Leading Companies: Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Mallinckrodt plc, Hetero Labs Limited, Granules India Limited, Glenmark Pharmaceuticals Limited, Ipca Laboratories Limited.
Key Takeaways for Senior Decision-Makers
- Advanced process technologies, including continuous manufacturing, are enabling improved throughput and minimizing operational variability for mesalamine API production.
- Stringent regulatory frameworks have prompted strategic investments in analytical technology, batch-to-batch consistency, and quality management systems among major API manufacturers.
- Supply chain resilience is strengthened by vertical integration and flexible procurement strategies, providing stability amid evolving tariff landscapes and cross-border trade uncertainties.
- Market segmentation by formulation, therapeutic application, and delivery route drives targeted product development, reflecting diverse clinical requirements for ulcerative colitis and Crohn’s disease.
- Sustainability initiatives such as solvent recovery and green chemistry are shaping industry best practices, with collaborative partnerships emerging across the value chain.
Tariff Impact: 2025 U.S. Trade Adjustments
U.S. tariff adjustments introduced in 2025 have led to cost recalibrations and logistical strategy shifts. Manufacturers are emphasizing diversified sourcing and near-shoring to reduce exposure to new duties, while fixed-rate shipping and strategic warehouse placements help stabilize margins. The emergence of domestic production capabilities among contract organizations is strengthening supply chain resilience and regulatory oversight in response to these market conditions.
Mesalamine API: Methodology & Data Sources
This report integrates primary interviews with senior executives, engineers, and regulatory professionals, alongside secondary research analyzing technical literature, industry white papers, and regulatory filings. Peer-reviewed sources ground each insight, while benchmarking frameworks and scenario planning supplement the analytical rigor.
Why This Report Matters
- Empowers decision-makers to identify growth avenues and optimize product portfolios through actionable market segmentation and regional intelligence.
- Delivers clarity on regulatory shifts, supply chain strategies, and the latest manufacturing innovations to support informed strategic planning.
- Facilitates risk mitigation and opportunity capture by mapping evolving demand, supplier capabilities, and region-specific procurement trends.
Conclusion
The mesalamine API market continues to transform through process innovation, regional expansion, and regulatory adaptation. Industry leaders leveraging targeted insights and operational flexibility will be best equipped to navigate the evolving pharmaceutical landscape and secure long-term growth.
This product will be delivered within 1-3 business days.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
5.2. Emerging partnership models between small molecule developers and CMOs for mesalamine API production
5.3. Increasing pressure from generic mesalamine manufacturers driving API margin compression globally
5.4. Regulatory prioritization of green solvent usage in mesalamine API manufacturing processes
5.5. Clinical pipeline innovations combining mesalamine API with bioconjugates for targeted ulcerative colitis therapy
5.6. Impact of API supply chain disruptions in India and China on global mesalamine availability and pricing
6.2. PESTLE Analysis
8.2. Capsule
8.2.1. Enteric Coated Capsule
8.2.2. Nonenteric Capsule
8.3. Granules
8.4. Suspension
8.5. Tablet
8.5.1. Extended Release
8.5.2. Immediate Release
9.2. Crohn's Disease
9.2.1. Colonic
9.2.2. Ileal
9.2.3. Ileocolonic
9.3. Ulcerative Colitis
9.3.1. Mild
9.3.2. Moderate
9.3.3. Severe
10.2. Oral
10.3. Rectal
10.3.1. Enema
10.3.2. Suppository
11.2. Contract Manufacturing Organizations
11.2.1. Domestic
11.2.2. International
11.3. Generic Manufacturers
11.3.1. Mid Size
11.3.2. Small Scale
11.4. Pharma Companies
11.4.1. Generic Companies
11.4.2. Innovator Companies
12.2. Direct Tender
12.2.1. Government Tender
12.2.2. Hospital Tender
12.3. Distributors
12.3.1. National Distributors
12.3.2. Regional Distributors
12.4. Online Platforms
12.4.1. B2B Portals
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Viatris Inc.
16.3.3. Sun Pharmaceutical Industries Ltd.
16.3.4. Dr. Reddy's Laboratories Ltd.
16.3.5. Cipla Ltd.
16.3.6. Mallinckrodt plc
16.3.7. Hetero Labs Limited
16.3.8. Granules India Limited
16.3.9. Glenmark Pharmaceuticals Limited
16.3.10. Ipca Laboratories Limited
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
FIGURE 2. GLOBAL MESALAMINE API MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MESALAMINE API MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MESALAMINE API MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MESALAMINE API MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MESALAMINE API MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MESALAMINE API MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MESALAMINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MESALAMINE API MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MESALAMINE API MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MESALAMINE API MARKET: RESEARCHAI
FIGURE 26. MESALAMINE API MARKET: RESEARCHSTATISTICS
FIGURE 27. MESALAMINE API MARKET: RESEARCHCONTACTS
FIGURE 28. MESALAMINE API MARKET: RESEARCHARTICLES
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MESALAMINE API MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MESALAMINE API MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MESALAMINE API MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MESALAMINE API MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MESALAMINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MESALAMINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MESALAMINE API MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MESALAMINE API MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MESALAMINE API MARKET SIZE, BY ENTERIC COATED CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MESALAMINE API MARKET SIZE, BY ENTERIC COATED CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MESALAMINE API MARKET SIZE, BY NONENTERIC CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MESALAMINE API MARKET SIZE, BY NONENTERIC CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MESALAMINE API MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MESALAMINE API MARKET SIZE, BY GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MESALAMINE API MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MESALAMINE API MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MESALAMINE API MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MESALAMINE API MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MESALAMINE API MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MESALAMINE API MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MESALAMINE API MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MESALAMINE API MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MESALAMINE API MARKET SIZE, BY COLONIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MESALAMINE API MARKET SIZE, BY COLONIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MESALAMINE API MARKET SIZE, BY ILEAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MESALAMINE API MARKET SIZE, BY ILEAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MESALAMINE API MARKET SIZE, BY ILEOCOLONIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MESALAMINE API MARKET SIZE, BY ILEOCOLONIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MESALAMINE API MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MESALAMINE API MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MESALAMINE API MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MESALAMINE API MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MESALAMINE API MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MESALAMINE API MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MESALAMINE API MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MESALAMINE API MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MESALAMINE API MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MESALAMINE API MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MESALAMINE API MARKET SIZE, BY ENEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MESALAMINE API MARKET SIZE, BY ENEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MESALAMINE API MARKET SIZE, BY SUPPOSITORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MESALAMINE API MARKET SIZE, BY SUPPOSITORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MESALAMINE API MARKET SIZE, BY DOMESTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MESALAMINE API MARKET SIZE, BY DOMESTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MESALAMINE API MARKET SIZE, BY INTERNATIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MESALAMINE API MARKET SIZE, BY INTERNATIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MESALAMINE API MARKET SIZE, BY MID SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MESALAMINE API MARKET SIZE, BY MID SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MESALAMINE API MARKET SIZE, BY SMALL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MESALAMINE API MARKET SIZE, BY SMALL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MESALAMINE API MARKET SIZE, BY GENERIC COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MESALAMINE API MARKET SIZE, BY GENERIC COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MESALAMINE API MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MESALAMINE API MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MESALAMINE API MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MESALAMINE API MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MESALAMINE API MARKET SIZE, BY GOVERNMENT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MESALAMINE API MARKET SIZE, BY GOVERNMENT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MESALAMINE API MARKET SIZE, BY HOSPITAL TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MESALAMINE API MARKET SIZE, BY HOSPITAL TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MESALAMINE API MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MESALAMINE API MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MESALAMINE API MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MESALAMINE API MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MESALAMINE API MARKET SIZE, BY B2B PORTALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MESALAMINE API MARKET SIZE, BY B2B PORTALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MESALAMINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MESALAMINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MESALAMINE API MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MESALAMINE API MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 183. CANADA MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 185. CANADA MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 186. CANADA MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 187. CANADA MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 188. CANADA MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 189. CANADA MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 190. CANADA MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 191. CANADA MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 192. CANADA MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 193. CANADA MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 194. CANADA MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 195. CANADA MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 196. CANADA MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 197. CANADA MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 198. CANADA MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 199. CANADA MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. CANADA MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. CANADA MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 202. CANADA MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 203. CANADA MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 204. CANADA MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 205. CANADA MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 206. CANADA MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 207. CANADA MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. CANADA MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. CANADA MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 210. CANADA MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 211. CANADA MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 212. CANADA MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 213. CANADA MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 214. CANADA MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 220. MEXICO MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 221. MEXICO MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 222. MEXICO MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 223. MEXICO MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 226. MEXICO MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 227. MEXICO MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 230. MEXICO MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 231. MEXICO MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. MEXICO MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY GENERIC MANUFACTURERS, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY PHARMA COMPANIES, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY DIRECT TENDER, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY ONLINE PLATFORMS, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA MESALAMINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 346. UNITED KINGDOM MESALAMINE API MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM MESALAMINE API MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM MESALAMINE API MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM M
Samples
LOADING...
Companies Mentioned
The companies profiled in this Mesalamine API market report include:- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Cipla Ltd.
- Mallinckrodt plc
- Hetero Labs Limited
- Granules India Limited
- Glenmark Pharmaceuticals Limited
- Ipca Laboratories Limited